ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "S01L" (22)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory    
Verteporfin (S01LA01) 1 products WHO-DDD DrugBank.ca 
L IPCI Visudyneampoule(s)1048.961157.2010 %Lyophilisate: Verteporfinum 15 mgCheplapharm Schweiz
GmbH		A / SLGtell a friend
Ranibizumab (S01LA04) 9 products WHO-DDD DrugBank.ca 
L IP  Byooviz 10 mg / mL 481.46540.0510 %Injection solution: Ranibizumabum 10 mg/mlSamsung Bioepis CH
GmbH		B / SLGtell a friend
L IP  Ranivisio 10 mg/mL 481.46540.0510 %Injection solution: Ranibizumabum 10 mg/mlBioeq AGB / SLGtell a friend
L IP  Ximluci 10 mg/ml 481.46540.0510 %Injection solution: Ranibizumabum 10 mg/mlSpirig HealthCare AGB / SLGtell a friend
LSIPIPCI LucentisDurchstechflasche(n) à 0.23 ml611.09673.0520 %Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/mlNovartis Pharma
Schweiz AG		B / SLGtell a friend
L IP  LucentisFertigspritze(n)611.09673.0520 %Injektionslösung zur intravitrealen Injektion in Fertigspritze: Ranibizumabum 10 mg/mlNovartis Pharma
Schweiz AG		B / SLGtell a friend
 SIPIPCI LucentisDurchstechflasche(n) à 0.23 mlk.A.Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/mlNovartis Pharma
Schweiz AG		BGtell a friend
  IP  Byooviz 10 mg / mL k.A.Injection solution: Ranibizumabum 10 mg/mlSamsung Bioepis CH
GmbH		BGtell a friend
  IP  Ximluci 10 mg/ml k.A.Injection solution: Ranibizumabum 10 mg/mlSpirig HealthCare AGBGtell a friend
 SIPIPCI LucentisDurchstechflasche(n) à 0.23 ml874.341020.15k.A.Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/mlNovartis Pharma
Schweiz AG		BGtell a friend
Aflibercept (S01LA05) 11 products WHO-DDD DrugBank.ca 
L IP  Eylea, 2 mg/0,05 mlDurchstechflasche(n)766.18836.3510 %Injection solution: Afliberceptum 2mg / 0.05mlBayer (Schweiz) AGB / SLGtell a friend
L IP  Eylea 8 mg/0.07 ml 766.18849.7010 %Injection solution: Afliberceptum 8mg / 0.07mlBayer (Schweiz) AGB / SLGtell a friend
L IP  Pavblu 40 mg/ml 549.84614.4010 %Injection solution: Afliberceptum 2mg / 0.05mlAmgen Switzerland AGB / SLGtell a friend
L IP  Afqlir 40 mg/ml 549.84614.4010 %Injection solution in prefilled syringe: Afliberceptum 2mg / 50µlSandoz
Pharmaceuticals AG		B / SLGtell a friend
L IP  Eylea 8 mg/0.07ml 766.18849.7010 %Injection solution in prefilled syringe: Afliberceptum 8mg / 0.07mlBayer (Schweiz) AGB / SLGtell a friend
L IP  Pavblu 40 mg/ml 549.84614.4010 %Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05mlAmgen Switzerland AGB / SLGtell a friend
L IP  Eylea 2 mg/0.05 ml 766.18836.3510 %Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µlBayer (Schweiz) AGB / SLGtell a friend
  IP  Afqlir 40 mg/ml k.A.Injection solution: Afliberceptum 2mg / 0.05mlSandoz
Pharmaceuticals AG		BGtell a friend
     aflibercept HORUS 40 mg/ ml k.A.Injection solution: Afliberceptum 2mg / 0.05mlHorus Pharma Suisse SABGtell a friend
     Yesafili 40 mg/ml k.A.Injection solution: Afliberceptum 2mg / 0.05mlMedius AGBGtell a friend
  IP  Eylea 2 mg/0.05 mlsyringe(s)913.481063.35k.A.Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µlBayer (Schweiz) AGBGtell a friend
Brolucizumab (S01LA06) 1 products WHO-DDD  
L IP  Beovu 120mg/1ml 652.91726.5010 %Injection solution in prefilled syringe: Brolucizumabum 120 mg/mlNovartis Pharma
Schweiz AG		B / SLGtell a friend
 show caption
 
ATC-Browser | Drugs A-Z | Recent Registrations
2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home